Continuing Education Material on Hematology
The recent years have witnessed major advances in the treatment of benign rare blood disorders such as hemophilia, sickle cell disease (SCD), and cold agglutinin disease (CAD). Moreover, new guidelines have been developed for the diagnosis and management of these blood disorders. Clinicians including hematologists and emergency department physicians need to remain up to date on the various aspects of management of these hematological disorders to diagnose, treat, and manage associated complications. Moreover, access to novel therapies remains challenging due to payer restrictions including step therapy policies. Hematologists and their care team need education on streamlining the prior authorization processes to prevent treatment delays.
Free Hematology CE Activities
The CME Outfitters Hematology Hub is designed to provide clinicians with the latest clinical practice guidelines, diagnostic strategies and tools, scientific updates on current and emerging therapies, latest guidelines to optimize the management of hematological disorders, and strategies to streamline prior authorization process. In addition, the Hematology Hub also provides patient education tools to empower patients to make informed decisions about their care and to navigate the prior authorization process.
Hemophilia
- Guidelines For The Management Of Hemophillia 2nd Edition
- Guidelines For Emergency Department Management Of Individuals With Hemophillia And Other Bleeding Disorders
- NHF Position Statement Regarding Standardized Prior Authorization
- HFA Prior Authorization Issue Brief
- HFA Issue Brief: Non-Medical Switching and Step Therapy
Hemophilia
- What is hemophilia A?
- What is hemophilia B?
- Treatment of hemophilia
- Types of prophylaxis
- What is an inhibitor?
- Who is at risk for developing an inhibitor?
- Treatment for inhibitors
- What types of bleeds are there?
- Preventing bleeding
- Costs and considerations
- Video: Prior Authorization in Hemophilia
Sickle Cell Disease